Recital 43, Regulation (EU) 2019/6

In forcesince 11 Dec 2018

The combined use of several antimicrobial active substances may represent a particular risk with respect to the development of antimicrobial resistance. Such combined use should be taken into account, therefore, when assessing whether to authorise a veterinary medicinal product.